TLR4 and endothelial dysfunction: In particular, a proposed mechanism concerns LPS binding to toll-like receptor 4 (TLR4), and a subsequent systemic inflammatory reaction mediated by the secretion of pro-inflammatory molecules and enhancement of pro-atherogenic receptors, as shown by studies linking receptors and molecules commonly recognized in atherosclerotic plaques and endothelial dysfunction phenotypes [23].